IMvigor130: Efficacy and safety from a phase III study of atezolizumab (atezo) as monotherapy or combined with platinum-based chemotherapy (PBC) vs placebo + PBC in previously untreated locally advanced or metastatic urothelial carcinoma (mUC)-Reference-Cited by-同舟云学术

IMvigor130: Efficacy and safety from a phase III study of atezolizumab (atezo) as monotherapy or combined with platinum-based chemotherapy (PBC) vs placebo + PBC in previously untreated locally advanced or metastatic urothelial carcinoma (mUC)

Published:2019-10 Issue: Volume:30 Page:v888-v889
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Grande E.,Galsky M.,Arranz Arija J.A.,De Santis M.,Davis I.D.,De Giorgi U.F.F.,Mencinger M.,Kikuchi E.,Garcia del Muro X.,Gumus M.,Özgüroğlu M.,Rezazadeh Kalebasty A.,Park S.H.,Alekseev B.Y.,Schutz F.A.B.,Li J.-R.,Mecke A.,Mariathasan S.,Thastrom A.,Bamias A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/30/Supplement_5/mdz394.047/30082832/mdz394.047.pdf

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy for advanced or metastatic urothelial carcinoma;Cochrane Database of Systematic Reviews;2023-10-09

2. Artificial intelligence aids in development of nanomedicines for cancer management;Seminars in Cancer Biology;2023-02

3. Management of bladder cancer in older patients;Japanese Journal of Clinical Oncology;2021-12-15

4. Immune Checkpoint Inhibitors for Genitourinary Cancers: Treatment Indications, Investigational Approaches and Biomarkers;Cancers;2021-10-28

5. Three-Dimensional Deep Noninvasive Radiomics for the Prediction of Disease Control in Patients With Metastatic Urothelial Carcinoma treated With Immunotherapy;Clinical Genitourinary Cancer;2021-10